Division of Product Quality Research, OTR/OPS, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Int J Pharm. 2013 Nov 18;456(2):353-6. doi: 10.1016/j.ijpharm.2013.08.083. Epub 2013 Sep 7.
Crystallization of nimodipine in liquid-filled soft gelatin capsule during storage was reported for some commercial products, resulting in product recalls due to product quality and more importantly safety concerns. In this study, a real time particle monitoring tool, focused beam reflectance measurement, was used to evaluate the precipitation conditions of nimodipine in co-solvents. Upon water addition, two particle populations were discovered, appearing at different percentage of water content. Two transitions (i.e. sudden increase in particle counts) were observed, possibility related to nucleation and crystal growth of nimodipine. Furthermore, lowering storage temperature increased the tendency of nimodipine precipitation. Most critically, it was determined that with certain excipient, the drug precipitation occurred at approximately 7% (w/w) water content. Considering that all the orally administered liquid filled soft gelatin capsule shells contain residue water content as plasticizer, moisture transfer from the shell to the formulation may occur during long term storage, resulting in drug precipitation, particularly under cold temperature conditions.
据报道,一些商业产品的充液软胶囊在储存过程中会出现尼莫地平结晶,这导致了产品召回,不仅是因为产品质量,更重要的是安全问题。在这项研究中,实时粒子监测工具——聚焦光束反射测量法,被用于评估共溶剂中尼莫地平的沉淀条件。在加水后,发现了两种粒子群,它们出现在不同的含水量百分比。观察到两个转变(即粒子计数突然增加),可能与尼莫地平的成核和晶体生长有关。此外,降低储存温度会增加尼莫地平沉淀的趋势。最重要的是,确定了在某些辅料存在的情况下,药物沉淀发生在大约 7%(w/w)的含水量。考虑到所有口服充液软胶囊壳都含有作为增塑剂的残留水分,在长期储存过程中,水分可能会从壳转移到制剂中,导致药物沉淀,尤其是在低温条件下。